How to Help Your Patients Find Symbravo in Stock: A Provider's Guide

Prescribing a medication is only half the equation — patients actually need to get it. For Symbravo (meloxicam 20 mg / rizatriptan 10 mg), a newly approved acute migraine medication, the gap between prescription and patient pickup can be significant. This guide gives providers concrete, actionable steps to help patients navigate pharmacy access, insurance hurdles, and cost barriers for Symbravo in 2026.

Understanding the Access Landscape

Symbravo was FDA-approved on January 30, 2025, and is manufactured by Axsome Therapeutics. As of 2026, it faces three primary access challenges:

Pharmacy stocking gaps: Many pharmacies — especially independent ones — don't routinely stock Symbravo yet.

Insurance barriers: Most Medicare Part D plans don't cover it; commercial coverage requires PA and often step therapy; Medicaid requires PA.

High cash price: Approximately $1,300–$1,420 for 9 tablets without insurance or savings programs.

Step 1: Start Prior Authorization at the Point of Prescribing

The single most impactful thing your office can do is submit prior authorization simultaneously with writing the prescription. This eliminates the lag between pharmacy rejection and your office response. Use your EHR's e-PA tools when possible — many now integrate with payer systems for faster turnaround. For the PA request, include:

Documentation of prior triptan trials — which drugs, doses, and outcomes (failure, intolerance, or inadequate response)

Migraine frequency, severity, and functional impairment (MIDAS or HIT-6 scores add objective weight)

Clinical rationale for dual-mechanism (NSAID + triptan) therapy over monotherapy

Relevant Phase 3 data: MOMENTUM and EMERGE trial results supporting use in patients with inadequate prior response to triptans or gepants

Step 2: Enroll Commercially Insured Patients in the Savings Program Before They Leave Your Office

The Symbravo On My Side Savings Program allows eligible commercially insured patients to pay as little as $10 for up to a 90-day supply. The key is getting patients enrolled before they go to the pharmacy — prescription abandonment at the counter due to sticker shock is preventable if the savings card is already in hand.

Action steps for your office:

Include the savings program number (866-496-2976) in patient discharge materials with every Symbravo prescription

Download savings cards from the Axsome patient support website and keep them available at checkout

Instruct staff to ask "Do you have commercial insurance?" before patients leave — Medicare/Medicaid patients are not eligible for this program

Step 3: Provide Samples for Immediate Needs

Contact your Axsome Therapeutics sales representative about obtaining physician samples. For patients experiencing a current access gap — waiting for PA approval or for a pharmacy to place an order — samples provide immediate therapeutic continuity. Document sample distribution in the patient's chart per your standard practice.

Step 4: Guide Patients to the Right Pharmacies

Tell patients explicitly which pharmacy types are most likely to have Symbravo in stock or be able to quickly order it. Your prescription encounter note or discharge instructions should include pharmacy guidance such as:

Try a large chain pharmacy first: CVS, Walgreens, Walmart Pharmacy, or Kroger

Call ahead and ask specifically: 'Do you have Symbravo 20 mg/10 mg tablets in stock?'

If not in stock, ask the pharmacy to special-order it — most can receive it within 1–2 business days

Step 5: Recommend medfinder to Help Patients Search Efficiently

Patients who leave your office with a prescription and run into pharmacy availability issues often give up — rather than continuing to call pharmacies. medfinder addresses this by calling pharmacies in the patient's area on their behalf and texting them results. This reduces patient burden and increases the likelihood of prescription fulfillment without requiring your staff to intervene.

Step 6: Have a Backup Plan

Have an agreed-upon backup prescription ready for patients who encounter access barriers. Generic Treximet (sumatriptan/naproxen) is the closest therapeutic alternative and is widely available at low cost. Gepants (Ubrelvy, Nurtec ODT) are appropriate for patients with cardiovascular contraindications. For a full clinical comparison, see Symbravo availability: what providers need to know in 2026.

Office Checklist: Every Symbravo Prescription

Submit prior authorization simultaneously with prescribing (for PA-required plans)

Confirm patient's insurance type — commercial, Medicare, Medicaid

Give commercially insured patients the On My Side Savings Program info (866-496-2976)

Recommend CVS, Walgreens, or Walmart Pharmacy as first call for stock checks

Recommend medfinder.com for efficient pharmacy search

Provide samples if available while waiting for PA or pharmacy order

Have a backup prescription plan (generic Treximet or gepant) ready if needed